Atlas Trials

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER

Clinical trial NCT03068130 · TERMINATED

Trial details

NCT number
NCT03068130
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Hypertension
Start date
2017-04-18
Primary completion
2020-09-30
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.